Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?

The accumulation and propagation in the brain of misfolded proteins is a pathological hallmark shared by many neurodegenerative diseases such as Alzheimer’s disease (Aβ and tau), Parkinson’s disease (α-synuclein), and prion disease (prion protein). Currently, there is no epidemiological evidence to...

Full description

Bibliographic Details
Main Authors: Diane L. Ritchie, Marcelo A. Barria
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/2/207
_version_ 1797416390197510144
author Diane L. Ritchie
Marcelo A. Barria
author_facet Diane L. Ritchie
Marcelo A. Barria
author_sort Diane L. Ritchie
collection DOAJ
description The accumulation and propagation in the brain of misfolded proteins is a pathological hallmark shared by many neurodegenerative diseases such as Alzheimer’s disease (Aβ and tau), Parkinson’s disease (α-synuclein), and prion disease (prion protein). Currently, there is no epidemiological evidence to suggest that neurodegenerative disorders are infectious, apart from prion diseases. However, there is an increasing body of evidence from experimental models to suggest that other pathogenic proteins such as Aβ and tau can propagate in vivo and in vitro in a prion-like mechanism, inducing the formation of misfolded protein aggregates such as amyloid plaques and neurofibrillary tangles. Such similarities have raised concerns that misfolded proteins, other than the prion protein, could potentially transmit from person-to-person as rare events after lengthy incubation periods. Such concerns have been heightened following a number of recent reports of the possible inadvertent transmission of Aβ pathology via medical and surgical procedures. This review will provide a historical perspective on the unique transmissible nature of prion diseases, examining their impact on public health and the ongoing concerns raised by this rare group of disorders. Additionally, this review will provide an insight into current evidence supporting the potential transmissibility of other pathogenic proteins associated with more common neurodegenerative disorders and the potential implications for public health.
first_indexed 2024-03-09T06:03:32Z
format Article
id doaj.art-a0362d91ed73419ba56523331044e98b
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T06:03:32Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-a0362d91ed73419ba56523331044e98b2023-12-03T12:07:22ZengMDPI AGBiomolecules2218-273X2021-02-0111220710.3390/biom11020207Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?Diane L. Ritchie0Marcelo A. Barria1National CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UKNational CJD Research & Surveillance Unit, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UKThe accumulation and propagation in the brain of misfolded proteins is a pathological hallmark shared by many neurodegenerative diseases such as Alzheimer’s disease (Aβ and tau), Parkinson’s disease (α-synuclein), and prion disease (prion protein). Currently, there is no epidemiological evidence to suggest that neurodegenerative disorders are infectious, apart from prion diseases. However, there is an increasing body of evidence from experimental models to suggest that other pathogenic proteins such as Aβ and tau can propagate in vivo and in vitro in a prion-like mechanism, inducing the formation of misfolded protein aggregates such as amyloid plaques and neurofibrillary tangles. Such similarities have raised concerns that misfolded proteins, other than the prion protein, could potentially transmit from person-to-person as rare events after lengthy incubation periods. Such concerns have been heightened following a number of recent reports of the possible inadvertent transmission of Aβ pathology via medical and surgical procedures. This review will provide a historical perspective on the unique transmissible nature of prion diseases, examining their impact on public health and the ongoing concerns raised by this rare group of disorders. Additionally, this review will provide an insight into current evidence supporting the potential transmissibility of other pathogenic proteins associated with more common neurodegenerative disorders and the potential implications for public health.https://www.mdpi.com/2218-273X/11/2/207neurodegenerative diseasesprion diseasetransmissionamyloid-betaprotein misfoldingprion-like
spellingShingle Diane L. Ritchie
Marcelo A. Barria
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Biomolecules
neurodegenerative diseases
prion disease
transmission
amyloid-beta
protein misfolding
prion-like
title Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
title_full Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
title_fullStr Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
title_full_unstemmed Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
title_short Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
title_sort prion diseases a unique transmissible agent or a model for neurodegenerative diseases
topic neurodegenerative diseases
prion disease
transmission
amyloid-beta
protein misfolding
prion-like
url https://www.mdpi.com/2218-273X/11/2/207
work_keys_str_mv AT dianelritchie priondiseasesauniquetransmissibleagentoramodelforneurodegenerativediseases
AT marceloabarria priondiseasesauniquetransmissibleagentoramodelforneurodegenerativediseases